Literature DB >> 2679093

Treatment of renal anemia with recombinant human erythropoietin.

R M Schaefer1, W H Hörl, S G Massry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2679093     DOI： 10.1159/000167996

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN： 0250-8095            Impact factor:   3.754


× No keyword cloud information.
  6 in total

1.  Picking up the tab for erythropoietin.

Authors:  R Gabriel
Journal:  BMJ       Date:  1991-02-02

2.  Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm.

Authors:  I C Macdougall; R D Hutton; I Cavill; G A Coles; J D Williams
Journal:  BMJ       Date:  1990-03-10

Review 3.  The use of erythropoietin in renal failure.

Authors:  I C Macdougall; R D Hutton; G A Coles; J D Williams
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

4.  Red cell lipid peroxidation and antioxidant system in haemodialysed patients: influence of recombinant human erythropoietin (r-HuEPO) treatment.

Authors:  M Boran; C Küçükaksu; M Balk; S Cetin
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

5.  Polymorphisms in two genes, IL-1B and ACE, are associated with erythropoietin resistance in Korean patients on maintenance hemodialysis.

Authors:  Kyung Hwan Jeong; Tae Won Lee; Chun Gyoo Ihm; Sang Ho Lee; Ju Young Moon
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

6.  Epoetin alfa in anaemic children or adolescents on regular dialysis.

Authors:  M G Bianchetti; I Hämmerli; C Roduit; T J Neuhaus; E P Leumann; O H Oetliker
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.